Table 3.
Responder | Non responder | OR | CI | p-value | |
---|---|---|---|---|---|
HCV |
25 |
8 |
1.59 |
0.78-3.23 |
0.18 |
No HCV |
27 |
17 |
|
|
|
IVDU |
23 |
6 |
1.91 |
0.86-4.23 |
0.08 |
No IVDU |
29 |
19 |
|
|
|
Treatment |
48 |
16 |
2.76 |
1.58-4.03 |
0.002 |
No Treatment |
4 |
9 |
|
|
|
TDF |
36 |
13 |
1.61 |
0.85-3.04 |
3.04 |
No TDF |
16 |
12 |
|
|
|
NNRTI* |
27 |
6 |
1.9 |
0.78-4.57 |
0.14 |
PI |
19 |
10 |
|
|
|
Male |
28 |
14 |
0.76 |
0.4-1.46 |
0.65 |
Female |
24 |
11 |
|
|
|
African descent |
12 |
8 |
1.34 |
0.68-2.61 |
0.4 |
No african descent |
40 |
17 |
|
|
|
Age < 40 |
18 |
10 |
0.85 |
0.44-1.64 |
0.21 |
Age > 40 |
34 |
15 |
|
|
|
BMI < 21 |
7 |
2 |
1.52 |
0.43-5.4 |
0.48 |
BMI > 21 |
45 |
23 |
|
|
|
Smoker |
32 |
13 |
1.29 |
0.68-2.49 |
0.42 |
Non smoker |
20 |
12 |
|
|
|
Vit D 30-75 nmol/L |
38 |
17 |
0.97 |
0.47-2.01 |
0.92 |
Vit D < 30 nmol/L |
15 |
7 |
|
|
|
Total | 52 | 25 |
*34/36 NNRTI patients received EFV.